202 related articles for article (PubMed ID: 30617596)
1. Concomitant association of giant cell arteritis and malignancy: a multicenter retrospective case-control study.
Deshayes S; Liozon E; Chanson N; Sacré K; Moulinet T; Blanchard-Delaunay C; Espitia O; Groh M; Versini M; Le Gallou T; Kahn JE; Grobost V; Humbert S; Samson M; Mourot Cottet R; Mazodier K; Dartevel A; Campagne J; Dumont A; Bienvenu B; Lambert M; Daumas A; Saadoun D; Aouba A; de Boysson H;
Clin Rheumatol; 2019 May; 38(5):1243-1249. PubMed ID: 30617596
[TBL] [Abstract][Full Text] [Related]
2. Risk of malignancy in patients with giant cell arteritis and polymyalgia rheumatica: a systematic review and meta-analysis.
Ungprasert P; Sanguankeo A; Upala S; Knight EL
Semin Arthritis Rheum; 2014 Dec; 44(3):366-70. PubMed ID: 25074657
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of ischemic complications in patients with giant cell arteritis presenting with apparently isolated polymyalgia rheumatica.
Narváez J; Estrada P; López-Vives L; Ricse M; Zacarías A; Heredia S; Gómez-Vaquero C; Nolla JM
Semin Arthritis Rheum; 2015 Dec; 45(3):328-33. PubMed ID: 26186807
[TBL] [Abstract][Full Text] [Related]
4. Development of Giant Cell Arteritis after Treating Polymyalgia or Peripheral Arthritis: A Retrospective Case-control Study.
Liozon E; de Boysson H; Dalmay F; Gondran G; Bezanahary H; Fauchais AL; Ly KH
J Rheumatol; 2018 May; 45(5):678-685. PubMed ID: 29545449
[TBL] [Abstract][Full Text] [Related]
5. Risk factors and predictive models of giant cell arteritis in polymyalgia rheumatica.
Rodriguez-Valverde V; Sarabia JM; González-Gay MA; Figueroa M; Armona J; Blanco R; Fernández-Sueiro JL; Martínez-Taboada VM
Am J Med; 1997 Apr; 102(4):331-6. PubMed ID: 9217613
[TBL] [Abstract][Full Text] [Related]
6. The Incidence and Predictors of Solid- and Hematological Malignancies in Patients with Giant Cell Arteritis: A Large Real-World Database Study.
Dar L; Ben-Shabat N; Tiosano S; Watad A; McGonagle D; Komaneshter D; Cohen A; Bragazzi NL; Amital H
Int J Environ Res Public Health; 2021 Jul; 18(14):. PubMed ID: 34300046
[TBL] [Abstract][Full Text] [Related]
7. Polymyalgia rheumatica in biopsy proven giant cell arteritis does not constitute a different subset but differs from isolated polymyalgia rheumatica.
González-Gay MA; García-Porrúa C; Vázquez-Caruncho M
J Rheumatol; 1998 Sep; 25(9):1750-5. PubMed ID: 9733456
[TBL] [Abstract][Full Text] [Related]
8. The clinical and laboratory course of polymyalgia rheumatica/giant cell arteritis after the first two months of treatment.
Kyle V; Hazleman BL
Ann Rheum Dis; 1993 Dec; 52(12):847-50. PubMed ID: 8311533
[TBL] [Abstract][Full Text] [Related]
9. The spectrum of giant cell arteritis and polymyalgia rheumatica: revisiting the concept of the disease.
Dejaco C; Duftner C; Buttgereit F; Matteson EL; Dasgupta B
Rheumatology (Oxford); 2017 Apr; 56(4):506-515. PubMed ID: 27481272
[TBL] [Abstract][Full Text] [Related]
10. Association of giant cell arteritis and polymyalgia rheumatica with different tumor necrosis factor microsatellite polymorphisms.
Mattey DL; Hajeer AH; Dababneh A; Thomson W; González-Gay MA; García-Porrúa C; Ollier WE
Arthritis Rheum; 2000 Aug; 43(8):1749-55. PubMed ID: 10943865
[TBL] [Abstract][Full Text] [Related]
11. Development of ischemic complications in patients with giant cell arteritis presenting with apparently isolated polymyalgia rheumatica: study of a series of 100 patients.
Hernández-Rodríguez J; Font C; García-Martínez A; Espígol-Frigolé G; Sanmartí R; Cañete JD; Grau JM; Cid MC
Medicine (Baltimore); 2007 Jul; 86(4):233-241. PubMed ID: 17632265
[TBL] [Abstract][Full Text] [Related]
12. A longitudinal study of anticardiolipin antibody in polymyalgia rheumatica and giant cell arteritis.
Chakravarty K; Pountain G; Merry P; Byron M; Hazleman B; Scott DG
J Rheumatol; 1995 Sep; 22(9):1694-7. PubMed ID: 8523347
[TBL] [Abstract][Full Text] [Related]
13. Giant cell arteritis of myometrial and axillary arteries and polymyalgia rheumatica.
Kyle V; Dutoit SH; Elias-Jones J; Hazleman B
Ann Rheum Dis; 1987 Mar; 46(3):256-8. PubMed ID: 3579393
[TBL] [Abstract][Full Text] [Related]
14. HLA-DR4 in giant cell arteritis: association with polymyalgia rheumatica syndrome.
Richardson JE; Gladman DD; Fam A; Keystone EC
Arthritis Rheum; 1987 Nov; 30(11):1293-7. PubMed ID: 3500727
[TBL] [Abstract][Full Text] [Related]
15. Association between infection and the onset of giant cell arteritis and polymyalgia rheumatica: a systematic review and meta-analysis.
Pacoureau L; Barde F; Seror R; Nguyen Y
RMD Open; 2023 Nov; 9(4):. PubMed ID: 37949615
[TBL] [Abstract][Full Text] [Related]
16. Large-vessel involvement in giant cell arteritis and polymyalgia rheumatica.
Muratore F; Pazzola G; Pipitone N; Boiardi L; Salvarani C
Clin Exp Rheumatol; 2014; 32(3 Suppl 82):S106-11. PubMed ID: 24854380
[TBL] [Abstract][Full Text] [Related]
17. Negative temporal artery biopsies: eventual diagnoses and features of patients with biopsy-negative giant cell arteritis compared to patients without arteritis.
Breuer GS; Nesher R; Nesher G
Clin Exp Rheumatol; 2008; 26(6):1103-6. PubMed ID: 19210879
[TBL] [Abstract][Full Text] [Related]
18. Polymyalgia rheumatica and giant cell arteritis--An ophthalmic emergency.
Durkin SR; Athanasiov PA; Crompton JL
Aust Fam Physician; 2006 Nov; 35(11):889-91. PubMed ID: 17099810
[TBL] [Abstract][Full Text] [Related]
19. Homocysteine levels in polymyalgia rheumatica and giant cell arteritis: influence of corticosteroid therapy.
Martinez-Taboada VM; Bartolome MJ; Fernandez-Gonzalez MD; Blanco R; Rodriguez-Valverde V; Lopez-Hoyos M
Rheumatology (Oxford); 2003 Sep; 42(9):1055-61. PubMed ID: 12730520
[TBL] [Abstract][Full Text] [Related]
20. Anticardiolipin antibodies in polymyalgia rheumatica-giant cell arteritis: association with severe vascular complications.
Espinoza LR; Jara LJ; Silveira LH; Martínez-Osuna P; Zwolinska JB; Kneer C; Aguilar JL
Am J Med; 1991 Apr; 90(4):474-8. PubMed ID: 2012088
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
